Content on this site is intended for US RESIDENTS ONLY

I Have Lupus Nephritis, But It Does Not Define Me

If your kidneys have been affected by lupus nephritis (LN), consider participating in the Tulip LN Study.

About the Tulip LN Study

Learn about the clinical research study and the investigational drug.

The goal of the Tulip LN Study is to find out whether anifrolumab, an investigational drug, may help improve kidney function for those people with lupus nephritis or kidney disease associated with lupus. During the study period, participants will continue to take their currently prescribed LN medications.

You may qualify if you:

  • Are between 18 to 70 years of age.
  • Have been diagnosed with systemic lupus erythematosus (SLE) or LN.
  • Have active LN disease.

Why participate?

  • The Tulip Program gives you the chance to be a part of research for LN.
  • You will be closely monitored by a physician with expertise in LN.
  • All participants will receive study medication and study-related care at no charge.


About LN

Living with LN can be challenging, but you are not alone.

SLE is the form of the disease most commonly known as lupus. When lupus affects the kidneys, it is called LN. In such instances, the tiny filters in the kidneys become damaged resulting in inflammation and reduced kidney function.

Not everyone will require medication for LN, but for those who do, it is important to preserve kidney function early.

The Tulip Program represents AstraZeneca’s commitment to developing a potential new investigational drug for lupus. It is only through clinical research that new investigational drugs can be developed, and participating in a clinical trial may allow you to play an even more active role in lupus research. It also helps our researchers, physicians, and participants better understand lupus.

Frequently Asked Questions (FAQs)

FAQs about clinical research studies

FAQs about the Tulip LN Study

For more information about the Tulip LN Study, call 866-914-7346.

As a symbol of beauty, the tulip is known for its fragile yet colorful petals. Year after year, the flower blooms to display its vibrancy and resilience. In a similar way, the Tulip Program constantly strives for the people living with lupus, so they can open up to life again and showcase their own beautiful lives.

Back to Top

Welcome to the Tulip Program

The Tulip Program is a series of clinical research studies evaluating an investigational drug for systemic lupus erythematosus (SLE) and lupus nephritis (LN).

Content on this site is intended for US RESIDENTS ONLY

By choosing to continue, you are confirming that you reside in the United States.

Continue to Site